& # 39; YouTube videos & # 39; to trust on dangerous | & nbspPhoto Credits: & nbspThinkstock
New York: Researchers provided the most popular YouTube videos on cancer treatment, misleading or biased medical information that posed potential health risks to patients. The study of the 150 most reviewed videos on prostate cancer has found that 77 percent actually contain errors or biased content in the video or comment section.
While 75 percent of the videos fully explain the benefits of various treatments, only 53 percent have sufficiently captured potential losses and side effects. The other 19 percent recommend unresolved alternative or free therapies.
Eri Our study demonstrates that people really need to avoid many YouTube videos on prostate cancer, konusunda said Stacy Loeb, an Assistant Professor at New York University's School of Medicine. "They have valuable information, but they need to control the source to ensure people's credibility and to see how the videos are obsolete with the continuous improvement of resources with science," he added.
The study, published in the European Journal of Urology, showed that the mass of these videos was large and the average total imaging was over 45,000, but over 1.3 million. More than 600,000 prostate cancer videos are published on the social media platform.
The researchers noted that a drug that "injects the veins" in a prostate in a video that is caught in a cancer is a potentially harmful sample that it can make a claim that is not supported by medical evidence. In addition, only 50 percent of the analyzed videos describe & shared decision making at, the current standard of care in prostate cancer screening and treatment.
According to the principles of the 2017 American Urology Association, men between the ages of 55 and 69 should talk with their doctors about the risks and benefits of blood test screening for prostate cancer.
However, many popular videos are leading this change and at the same time encouraging more aggressive treatment than is considered medically necessary for low-risk disease, said Loeb.
He suggested that patients should take part in video-sharing platforms such as YouTube to produce content that provides evidence-based recommendations to refer their patients to trusted sources for information about prostate cancer.